A phase 1, randomized, placebo-controlled, single-and multiple-dose, double-blind study to evaluate the pharmacokinetics and safety of rimegepant orally disintegrating tablets 75 mg in healthy Chinese adults

被引：0
作者：
Li, Y. [1 ]
Bertz, R. [2 ]
Goodrich, R.
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China
[2] Biohaven Pharmaceut, New Haven, CT USA
来源：
HEADACHE | 2022年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB-P-19
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [31] Phase I, Randomized, Double-blind, Placebo-controlled, Single-dose, and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine
    de Hoon, Jan
    Van Hecken, Anne
    Vandermeulen, Corinne
    Yan, Lucy
    Smith, Brian
    Chen, Jiyun Sunny
    Bautista, Edgar
    Hamilton, Lisa
    Waksman, Javier
    Thuy Vu
    Vargas, Gabriel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (05) : 815 - 825
  • [32] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
  • [33] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V
    Goadsby, P. J.
    HEADACHE, 2021, 61 : 98 - 99
  • [34] Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design
    Wu, Min
    Li, Cuiyun
    Zhang, Hong
    Sun, Jixuan
    Zhu, Xiaoxue
    Li, Xiaojiao
    Gao, Xuedong
    Wang, Wei
    Ding, Yanhua
    CNS DRUGS, 2020, 34 (08) : 867 - 877
  • [35] Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design
    Min Wu
    Cuiyun Li
    Hong Zhang
    Jixuan Sun
    Xiaoxue Zhu
    Xiaojiao Li
    Xuedong Gao
    Wei Wang
    Yanhua Ding
    CNS Drugs, 2020, 34 : 867 - 877
  • [36] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, Robert
    Lipton, Richard
    Thiry, Alexandra
    Kamen, Lisa
    Coric, Vlad
    Goadsby, Peter
    NEUROLOGY, 2021, 96 (15)
  • [37] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1) : 19 - 19
  • [38] A phase I, randomized, double-blind, placebo-controlled, single-and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Na(v)1.8 inhibitor, in healthy adults
    Hijma, Hemme J.
    van Brummelen, Emilie M. J.
    Siebenga, Pieter S.
    Groeneveld, Geert Jan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (04): : 981 - 993
  • [39] Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo-Controlled, Multiple-Dose Study
    Yu, Brian
    Adedoyin, Adedayo
    Hershberger, Ellie
    Caro, Luzelena
    Xiao, Alan
    Rhee, Elizabeth G.
    Huntington, Jennifer A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (04): : 382 - 391
  • [40] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Camilo, Juan
    Ferreira, Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
12345